NCT02138539|CompletedPhase 4
Evaluation of an Herbal-Based De-Pigmenting System
A Clinical Usage Study to Evaluate the Safety and Efficacy of an Herbal-Based De-Pigmenting System
Loading search results
A Clinical Usage Study to Evaluate the Safety and Efficacy of an Herbal-Based De-Pigmenting System
Sponsor study identifier
interventional
28
1 country
1
Study Start
October 2013
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2014
Actual (reported)Study Completion
October 2014
Actual (reported)The purpose of this study is to evaluate the effectiveness and tolerability of an herbal de-pigmenting regimen applied to one side of the face compared with hydroquinone applied to the other side of the face in treating mottled hyperpigmentation and melasma.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2014
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2013
Date type not reportedThis date has not been verified as actual or estimated.
February 26, 2014
Actual (reported)May 14, 2014
Actual (reported)October 2014
Actual (reported)October 2014
Actual (reported)Melanin Index
The melanin index of the skin will be measured at baseline and at each follow-up visit with a non-invasive device. At the end of the study, the change of the Melanin index over a period of 6 months will be calculated.
6 months
Irritation
Baseline, 1 month, 2 month, 4 month, 6 months
4% hydroquinone applied to one side of the face.
Herbal depigmenting agent applied on the other side of the face.
A two product herbal pigmentation reducing regimen is applied twice a day to either the left or right side of the face for a duration of 4 months.
Hydroquinone 4% is applied twice a day to either the left or right side of the face for a duration of 4 months.
Sadick Research Group
New York, New York, 10075, United States
Neil S Sadick, MD
Sadick Research Group
28 participants (actual enrollment reported by the registry).
First Submitted
February 26, 2014
First Posted
May 14, 2014
Study Start
October 2013
Date type not reportedThis date has not been verified as actual or estimated.
Oral Tranexamic Acid and Laser for Treatment of Melasma
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
October 2014
Actual (reported)Study Completion
October 2014
Actual (reported)Last Updated
November 18, 2015
Record last verified: 2015-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: